TY - JOUR T1 - Modeling MRSA decolonization: Interactions between body sites and the impact of site-specific clearance JF - medRxiv DO - 10.1101/2020.11.30.20239798 SP - 2020.11.30.20239798 AU - Onur Poyraz AU - Mohamad R. A. Sater AU - Loren G. Miller AU - James A. McKinnell AU - Susan S. Huang AU - Yonatan H. Grad AU - Pekka Marttinen Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/12/08/2020.11.30.20239798.abstract N2 - Methicillin-resistant Staphylococcus aureus (MRSA) can colonize multiple body sites, and carriage is a risk factor for infection. Successful decolonization protocols reduce disease incidence; however, multiple protocols exist, comprising diverse therapies targeting multiple body sites, and the optimal protocol is unclear. Standard methods are inadequate to infer the impact of site-specific components on successful decolonization. Here, we formulate a Bayesian coupled hidden Markov model (CHMM), which estimates interactions between body sites, quantifies the contribution of each therapy to successful decolonization, and enables predictions of the efficacy of therapy combinations. We applied the model to longitudinal data from a randomized controlled trial (RCT) of an MRSA decolonization protocol consisting of chlorhexidine body and mouthwash and nasal mupirocin. Our findings 1) confirmed nares as a central hub for MRSA colonization and nasal mupirocin as the most crucial therapy, and 2) demonstrated that all components contributed significantly to the efficacy of the protocol and the protocol reduced self-inoculation. Finally, we assessed the impact of hypothetical increases on the effectiveness of each therapy in silico and found that enhancing MRSA clearance at the skin would yield the largest gains to the overall decolonization regimen. This study demonstrates the use of advanced modeling to go beyond what is typically achieved by RCTs, enabling evidence-based decision-making to streamline clinical protocols.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT01209234Clinical Protocols https://doi.org/10.1056/NEJMoa1716771 Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We used the data from https://doi.org/10.1056/NEJMoa1716771. This trial was approved by the institutional review board of the University of California Irvine. For more details about the data collection, please see the original article https://doi.org/10.1056/NEJMoa1716771I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe CLEAR (Changing Lives by Eradicating Antibiotic Resistance) Trial demonstrated that the use of a post-discharge decolonization protocol in MRSA carriers reduces infection and hospitalization rates; ClinicalTrial.gov number NCT01209234, see reference https://doi.org/10.1056/NEJMoa1716771 for informed consent and institutional review board approvals. The data used in the present article is available on request from the corresponding author Susan Huang of the https://doi.org/10.1056/NEJMoa1716771, a co-author of this study. ER -